Autonomix Medical wins Canadian patent for catheter-based transvascular nerve therapy platform

Bitget2026/10/02 12:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Autonomix Medical received a Canadian patent covering catheter-based transvascular tools that access tissue beyond blood vessel walls.
Protection supports its platform for precision nerve-targeted therapies, including real-time physiological feedback to guide delivery and confirm effect.
Portfolio now totals 112 issued or pending patent applications worldwide, with related patents already issued in the US and Europe.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020805PRIMZONEFULLFEED9838298) on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Autonomix Medical wins Canadian patent for catheter-based transvascular nerve therapy platform

You may also like

Crypto prices